United States · Exchanges & live quotes · Nasdaq

Eli Lilly Is Much More Than a Weight-Loss Drug Company. Here's the Evidence

Published by Nasdaq · United States 1 h ago

Key PointsSome of Eli Lilly’s products beyond its core therapeutic area are performing well.

Read the full article on Nasdaq Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)

Also worth reading

Wall Street’s “Energy Transition” Funds Are Packed With Natural Gas

U.S. economy adds a robust 165,000 jobs in October

New Federal Data Reveals How Much Americans Spend in Retirement

Canton Coin Surges 3.06% Amid Positive SEC News, Tokenization

Cboe Global Markets

Tech Stocks Rebound but Nasdaq Is Still in Correction Territory

New capabilities to power agents at scale with Google's Agentic Data Cloud